P1.15-23 Factors Affecting Treatment in Non-Small Cell Lung Cancer Patients

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.955
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

P1.15-02 Migration Differences in Small Cell vs Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P1.15-32 Real World EGFR Mutation Profile From 1699 Non-Small Cell Lung Cancer Patients in Eastern China

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

MA14.11 Factors Associated With Early Mortality in Non-Small Cell Lung Cancer Patients Following Systemic Anti-Cancer Treatment

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Immune-Checkpoint Inhibitor Treatment of Non-Small Cell Lung Cancer Patients

Jurnal Respirasi
2020English

Social Factors, Treatment, and Survival in Early-Stage Non-Small Cell Lung Cancer.

American Journal of Public Health
EnvironmentalPublic HealthOccupational Health
1998English

Afatinib Treatment in Advanced Non-Small Cell Lung Cancer

Lung Cancer: Targets and Therapy
Oncology
2011English

Individualization of Treatment in Non-Small Cell Lung Cancer

F1000 Medicine Reports
2009English

P1.15-28 Real World Treatment Patterns and Survival of Stage IV Non-Small Cell Lung Cancer (NSCLC) in Ontario, Canada

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Advanced Non-Small Cell Lung Cancer in Elderly Patients

Breathe
PulmonaryRespiratory Medicine
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy